Cryoballoon atrial fibrillation ablation: Single‐center safety and efficacy data using a novel cryoballoon technology compared to a historical balloon platform
Journal of Cardiovascular Electrophysiology2021Vol. 32(3), pp. 588–594
Citations Over TimeTop 10% of 2021 papers
Adriano Nunes Kochi, Massimo Moltrasio, Fabrizio Tundo, Stefania Riva, Ciro Ascione, Maria Antonietta Dessanai, Francesca Pizzamiglio, Giulia Vettor, Selene Cellucci, Alessio Gasperetti, Claudio Tondo, Gaetano Fassini
Abstract
The novel POLARx™ cryoballoon had similar efficacy and safety compared with the AFAP. It was also associated with longer procedural times, similar TTI, and lower minimum temperature reached.
Related Papers
- → Cryoablation of atrial fibrillation with the fourth‐generation balloon: The first reported case(2018)5 cited
- → Recurrent atrial fibrillation after initial cryoballoon ablation: New perspectives for intensive ablation in right superior pulmonary vein ostium for atrial fibrillation(2021)2 cited
- → Pulmonary Vein Isolation for Atrial Fibrillation using the Argon-based Cryoablation Probe: A Report of Early Experience from an Australian Centre(2010)
- → PP-130 The Isolation Time of Pulmonary Vein after Cryoablation for Atrial Fibrillation: Is There Any Prognostic Value?(2015)
- → Confirmation of Pulmonary Vein Isolation After Cryoablation of Atrial Fibrillation(2020)